Review
Open access
Aug 2026
Advances in therapeutics and vaccines for Marburg virus disease: challenges and future directions.
The human monoclonal antibody MR191N provides complete post-exposure protection in non-human primates and necessitates adaptive trial designs, expanded diagnostic models, and synergistic combination therapies to address MVD.
V. Kandi, F. Branda, Mohammed Alissa et al.
· Expert Review of Anti-Infect... · 0 citations